All events
13 Oct 2025
We are pleased to announce that Maiwald Intellectual Property will participate as a Platinum Partner at the upcoming Life Sciences Strategy Summit on IP & Exclusivity, taking place in the Infinity Hotel & Conference Resort Munich from 13–15 October 2025.
Dr. Eva Ehlich, Partner at Maiwald, will serve as Event Co-Chair and Panel Chair.
She will lead a key session on Antibody Exclusivity Challenges Considering the Post-G2/21 and Amgen vs Sanofi Landscape
The session will address:
Dr. Ehlich will be joined by senior legal and scientific representatives from Novartis, Amgen, and Sterne, Kessler, Goldstein & Fox.
In addition, Dr. Anja Fux will chair a session on EPO Board of Appeal Cases and the Effect Upon the Life Sciences Sector (Cases: G1/24, G2/21, T 1977/22, G1/23)
Discussion points include:
With over 400 participants expected, including in-house counsel and legal experts from originator, generic, and biotech companies, the summit provides a key platform for discussion and strategic exchange at the interface of law, science, and innovation.
More information and the full agenda are available here.
Topic
Maiwald Platinum Partner at the 2025 Life Sciences Strategy Summit on IP & Exclusivity
Date:
13 Oct 2025
Time:
Location:
Infinity Hotel & Conference Resort Munich
Register